U.S. flag

An official website of the United States government

NM_007325.5(GRIA3):c.15G>A (p.Lys5=) AND not specified

Germline classification:
Benign (2 submissions)
Last evaluated:
Mar 29, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000117155.17

Allele description [Variation Report for NM_007325.5(GRIA3):c.15G>A (p.Lys5=)]

NM_007325.5(GRIA3):c.15G>A (p.Lys5=)

Gene:
GRIA3:glutamate ionotropic receptor AMPA type subunit 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
Xq25
Genomic location:
Preferred name:
NM_007325.5(GRIA3):c.15G>A (p.Lys5=)
HGVS:
  • NC_000023.11:g.123184550G>A
  • NG_009377.2:g.5308G>A
  • NM_000828.5:c.15G>A
  • NM_001256743.2:c.15G>A
  • NM_007325.5:c.15G>AMANE SELECT
  • NP_000819.3:p.Lys5=
  • NP_000819.4:p.Lys5=
  • NP_001243672.1:p.Lys5=
  • NP_015564.5:p.Lys5=
  • NC_000023.10:g.122318402G>A
  • NM_000828.4:c.15G>A
  • p.Lys5Lys
Links:
dbSNP: rs61740996
NCBI 1000 Genomes Browser:
rs61740996
Molecular consequence:
  • NM_000828.5:c.15G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001256743.2:c.15G>A - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_007325.5:c.15G>A - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000151319Genetic Services Laboratory, University of Chicago
no assertion criteria provided
Likely benigngermlineclinical testing

SCV000613543Athena Diagnostics
criteria provided, single submitter

(Athena Diagnostics Criteria)
Benign
(Mar 29, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A Standardized DNA Variant Scoring System for Pathogenicity Assessments in Mendelian Disorders.

Karbassi I, Maston GA, Love A, DiVincenzo C, Braastad CD, Elzinga CD, Bright AR, Previte D, Zhang K, Rowland CM, McCarthy M, Lapierre JL, Dubois F, Medeiros KA, Batish SD, Jones J, Liaquat K, Hoffman CA, Jaremko M, Wang Z, Sun W, Buller-Burckle A, et al.

Hum Mutat. 2016 Jan;37(1):127-34. doi: 10.1002/humu.22918. Epub 2015 Oct 29.

PubMed [citation]
PMID:
26467025
PMCID:
PMC4737317

Details of each submission

From Genetic Services Laboratory, University of Chicago, SCV000151319.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Athena Diagnostics, SCV000613543.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024